IL172647A0 - Compositions of lipopeptide antibiotic derivatives and methods of use thereof - Google Patents

Compositions of lipopeptide antibiotic derivatives and methods of use thereof

Info

Publication number
IL172647A0
IL172647A0 IL172647A IL17264705A IL172647A0 IL 172647 A0 IL172647 A0 IL 172647A0 IL 172647 A IL172647 A IL 172647A IL 17264705 A IL17264705 A IL 17264705A IL 172647 A0 IL172647 A0 IL 172647A0
Authority
IL
Israel
Prior art keywords
compositions
methods
lipopeptide antibiotic
antibiotic derivatives
derivatives
Prior art date
Application number
IL172647A
Other languages
English (en)
Original Assignee
Migenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Migenix Inc filed Critical Migenix Inc
Publication of IL172647A0 publication Critical patent/IL172647A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL172647A 2003-07-17 2005-12-18 Compositions of lipopeptide antibiotic derivatives and methods of use thereof IL172647A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48833103P 2003-07-17 2003-07-17
US56491204P 2004-04-23 2004-04-23
PCT/US2004/021039 WO2005000878A2 (en) 2003-06-26 2004-06-28 Compositions of lipopeptide antibiotic derivatives and methods of use thereof

Publications (1)

Publication Number Publication Date
IL172647A0 true IL172647A0 (en) 2006-04-10

Family

ID=36203969

Family Applications (1)

Application Number Title Priority Date Filing Date
IL172647A IL172647A0 (en) 2003-07-17 2005-12-18 Compositions of lipopeptide antibiotic derivatives and methods of use thereof

Country Status (11)

Country Link
US (1) US7868135B2 (enExample)
EP (2) EP2147925A1 (enExample)
JP (1) JP2007536200A (enExample)
CN (1) CN1839150A (enExample)
AU (1) AU2004252174A1 (enExample)
CA (1) CA2530063A1 (enExample)
EA (1) EA010294B1 (enExample)
IL (1) IL172647A0 (enExample)
NZ (1) NZ544750A (enExample)
WO (1) WO2005000878A2 (enExample)
ZA (1) ZA200600008B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7951232B2 (en) * 2006-02-09 2011-05-31 Elevance Renewable Sciences, Inc. Surface coating compositions and methods
CA2641991A1 (en) * 2006-02-09 2007-08-16 Elevance Renewable Sciences, Inc. Antimicrobial compositions, methods and systems
GB0821540D0 (en) * 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
RU2532222C2 (ru) 2009-02-16 2014-10-27 Серенис Терапьютикс Холдинг С.А, Миметики аполипопротеина а-i
DE102009060102A1 (de) * 2009-12-21 2011-06-22 Martin-Luther-Universität Halle-Wittenberg, 06108 Derivatisierungsreagenzien zur tandem-massenspektrometrischen Quantifizierung von Proteinen
BR112012021931A2 (pt) * 2010-03-09 2016-05-31 Merck Canada Inc composto, composição farmacêutica, método para tratar uma infecção bacteriana, e, uso de composto
ES2374779B1 (es) * 2010-03-10 2012-12-27 Universidad De Barcelona Compuestos péptidicos útiles como agentes antibacterianos.
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
WO2012166665A2 (en) * 2011-05-27 2012-12-06 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
EP2703410B1 (en) * 2012-08-28 2015-10-14 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie Jagaricin, derivatives, and uses thereof
CA2892027A1 (en) 2012-11-21 2014-05-30 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
RU2016146581A (ru) 2014-05-20 2018-06-21 АрКьюЭкс ФАРМАСЪЮТИКЛС, ИНК. Макроциклические антибиотики широкого спектра действия
US9856292B2 (en) * 2014-11-14 2018-01-02 Bristol-Myers Squibb Company Immunomodulators
CN104557743A (zh) * 2014-12-02 2015-04-29 南京邮电大学 一类包含不饱和脂肪酸结构的抗白色念珠菌药物及其制备方法
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
CN104817619B (zh) * 2015-04-23 2018-07-17 浙江大学 抗菌化合物及其应用
CN105231000B (zh) * 2015-09-25 2020-01-07 广东海洋大学 一种利用水产品下脚料生产抗菌营养复合型饲料添加剂的方法
EP3377474B1 (en) 2015-11-20 2023-08-16 RQX Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
JP2020513036A (ja) * 2017-04-05 2020-04-30 レボリューション メディシンズ インコーポレイテッドＲｅｖｏｌｕｔｉｏｎ Ｍｅｄｉｃｉｎｅｓ，Ｉｎｃ． 協同的結合に関与する化合物及びその使用
CN109593808B (zh) * 2017-09-30 2022-10-04 上海医药工业研究院 达托霉素发酵培养基及其制备方法
JP6770553B2 (ja) * 2018-07-20 2020-10-14 藤本化学製品株式会社 アルコキシフェニル誘導体、ヌクレオシド保護体およびヌクレオチド保護体、オリゴヌクレオチド製造方法、ならびに、置換基除去方法
JP7296636B2 (ja) * 2018-07-20 2023-06-23 藤本化学製品株式会社 アルコキシフェニル誘導体、ヌクレオシド保護体およびヌクレオチド保護体、オリゴヌクレオチド製造方法、ならびに、置換基除去方法
WO2020031083A1 (en) * 2018-08-06 2020-02-13 KHAN, Khalid Antimicrobial formulations comprising vancomycin or tobramycin
CN111434775B (zh) * 2019-01-11 2022-12-06 上海医药工业研究院 一种发酵制备达托霉素的方法
IL295889B2 (en) 2019-05-28 2025-01-01 Hoffmann La Roche Broad-spectrum macrocyclic antibiotic
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения
CN112625106B (zh) * 2021-01-13 2023-03-31 兰州大学 一种抗菌多肽化合物、合成方法及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB923544A (en) 1959-07-21 1963-04-10 Takeda Pharmaceutical A new antibiotic-glumamycin
US3057779A (en) 1960-03-14 1962-10-09 American Cyanamid Co Antibiotic and production thereof
US3639582A (en) 1967-04-14 1972-02-01 Zaidan Hojin Biseibutsu Antibiotic laspartomycin
DE1800363A1 (de) 1967-10-04 1969-07-03 Shionogi & Co Tsushimycin und seine Herstellung
FR2124060B1 (enExample) 1971-02-02 1974-04-12 Rhone Poulenc Sa
IL61604A (en) 1977-07-22 1981-10-30 Baxter Travenol Lab Flexible collapsible containers
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4977083A (en) 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US4994270A (en) 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
US5039789A (en) 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US5028590A (en) 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
TW455591B (en) 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
WO1997047738A1 (en) 1996-06-13 1997-12-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic lipopeptide acylase
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
AU7893301A (en) * 2000-07-17 2002-01-30 Intrabiotics Pharmaceuticals Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6716962B2 (en) 2000-07-17 2004-04-06 Micrologix Biotech Inc. Extractive purification of lipopeptide antibiotics
JP4402463B2 (ja) 2002-01-03 2010-01-20 マイジェニックス インコーポレイテッド リポペプチド抗生物質のＤａｂ９誘導体およびそれを製造および使用する方法

Also Published As

Publication number Publication date
WO2005000878A3 (en) 2005-06-16
EP2147925A1 (en) 2010-01-27
EP1656390A2 (en) 2006-05-17
NZ544750A (en) 2009-06-26
EA200600280A1 (ru) 2006-10-27
WO2005000878A2 (en) 2005-01-06
WO2005000878A8 (en) 2006-06-08
AU2004252174A1 (en) 2005-01-06
CN1839150A (zh) 2006-09-27
EA010294B1 (ru) 2008-08-29
ZA200600008B (en) 2007-09-26
CA2530063A1 (en) 2005-01-06
US7868135B2 (en) 2011-01-11
JP2007536200A (ja) 2007-12-13
US20050153876A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
IL172647A0 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
AU2003259735A8 (en) Small-mer compositions and methods of use
IL219406A0 (en) Antiloading compositions and methods of selecting same
IL172689A0 (en) Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE
EP1551376A4 (en) IMMUNOMODULATORY COMPOSITIONS, THEIR METHODS OF PREPARATION AND USE
EP1696910A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF FIBROSIS
AU2003299441A8 (en) Nf-hev compositions and methods of use
TWI339662B (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
HUP0302867A3 (en) Parasiticidal compositions and methods of their use
AU2003239868A8 (en) Sunscreen compositions and methods of use thereof
EP1765321A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHOD OF USE THEREOF
PT1667693E (pt) Composições e métodos para usar corpos lamelares com fins terapêuticos
GB0324523D0 (en) Compositions and methods of treatment
IL155545A0 (en) Novel solvate form of cabergoline and uses thereof
IL180195A0 (en) Aequorin-containing compositions and methods of using same
IL174325A0 (en) Dna vaccine compositions and methods of use
AU2003291458A8 (en) Pharmaceutical compositions and methods of using taxane derivatives
GB0327050D0 (en) Therapeutic methods compositions and uses
AU2003290647A8 (en) Pharmaceutical compositions and methods of using taxane derivatives
ZA200801151B (en) Solvate of cabergoline and preparations of cabergoline Form 1
PL1667693T3 (pl) Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych
AU2003220601A1 (en) Synergistic l-methadone compositions and methods of use thereof
IL177751A0 (en) Pharmaceutical composition of (+)-erythro-mefloquine and its use
AU2003905755A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
AU2003904094A0 (en) Compositions and methods of treatment